-
BKT140 (BL-8040): Driving CXCR4 Antagonism in Cancer Researc
2026-05-09
BKT140 (BL-8040) enables precise targeting of CXCR4-mediated chemotaxis and tumor microenvironment interactions, unlocking advanced workflows for oncology and stem cell mobilization research. This article delivers actionable protocol enhancements, troubleshooting strategies, and insights from the latest theranostic breakthroughs.
-
MCC950 Sodium: Precision NLRP3 Inflammasome Inhibition in Re
2026-05-09
MCC950 sodium (CRID3 sodium salt) enables highly selective, nanomolar inhibition of NLRP3 inflammasome activity, empowering researchers to dissect inflammatory and autoimmune mechanisms with exceptional specificity. This guide delves into best-practice workflows, advanced applications, and troubleshooting strategies to maximize experimental impact in disease modeling and translational research.
-
Protease Inhibitor Cocktail EDTA-Free: Precision in Protein
2026-05-08
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) empowers researchers to achieve uncompromising protein integrity, even in phosphorylation-sensitive workflows. Its EDTA-free design protects against serine, cysteine, and acid proteases without interfering with divalent cation-dependent assays, enabling robust results for advanced biochemical analyses.
-
AZD0156: ATM Kinase Inhibitor Workflows in Cancer Research
2026-05-07
AZD0156, a potent and selective ATM kinase inhibitor, enables high-specificity modulation of DNA damage response and checkpoint control in cancer research. This article delivers a protocol-driven, troubleshooting-focused guide, with insights from recent work on combinatorial therapy in ovarian cancer models.
-
Perphenazine in Host-Directed Immunomodulation & Neuropharma
2026-05-07
Explore how Perphenazine, a potent dopamine D2 receptor antagonist, uniquely bridges neuropharmacology with host-directed antibacterial strategies. This article reveals new mechanistic insights for mitochondria-mediated cell death and immunomodulation, empowering advanced assay development.
-
TPPU: Unveiling sEH Inhibition for Precision Lipidomics Rese
2026-05-06
Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, enables precision control of epoxyeicosatrienoic acids metabolism and fatty acid epoxide signaling. This article reveals cutting-edge insights on assay design and translational modeling, uniquely guiding researchers in chronic inflammation and redox biology.
-
Gene Expression Profiling Reveals HR Defects in Mesothelioma
2026-05-06
Borchert et al. (2019) systematically profiled homologous recombination (HR) gene expression in malignant pleural mesothelioma (MPM), uncovering that a subset of tumors with 'BRCAness' signatures are particularly susceptible to PARP inhibition. This work highlights the mechanistic link between HR pathway alterations, therapy resistance, and opportunities for precision combination therapies in MPM.
-
Anlotinib Hydrochloride: Precision Tools for Functional Angi
2026-05-05
Explore the unique multi-target action of Anlotinib hydrochloride—a potent tyrosine kinase inhibitor—on endothelial cell migration and angiogenesis. This article goes beyond standard reviews by decoding its assay-specific advantages and decision points for advanced cancer research.
-
Sulfo-NHS-SS-Biotin: Protocols and QC for Cleavable Labeling
2026-05-05
Sulfo-NHS-SS-Biotin is a water-soluble biotin disulfide N-hydroxysulfosuccinimide ester designed for efficient, amine-specific protein labeling in aqueous environments. It enables selective cell surface protein tagging for affinity purification or detection, with reversible label removal via disulfide cleavage. This reagent is not suitable for applications requiring stable intracellular protein labeling or extended solution stability.
-
Trametinib (GSK1120212): Applied Oncology Research Workflows
2026-05-04
Trametinib (GSK1120212) stands out as a highly potent, ATP-noncompetitive MEK1/2 inhibitor, empowering researchers to dissect the MEK-ERK pathway and its downstream effects on cell proliferation, apoptosis, and cell cycle regulation. This article translates the latest experimental and mechanistic findings—including APEX2/TERT regulation—into actionable protocols, troubleshooting guidance, and advanced applications for oncology and stem cell studies.
-
Technical Guide: FITC-Concanavalin A (ConA) Conjugate Use
2026-05-04
FITC-Concanavalin A (ConA) Conjugate addresses the challenge of specifically detecting α-D-glucose and α-D-mannose residues on cell surfaces in immunofluorescence and flow cytometry workflows. It should not be used for non-carbohydrate-binding assays or outside its defined storage conditions.
-
Toremifene in Breast Cancer: 20 Years of Endocrine Therapy I
2026-05-03
This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator, for postmenopausal breast cancer. It highlights innovations in personalized endocrine therapy, biomarker-driven approaches, and the nuanced positioning of SERMs relative to steroidal aromatase inhibitors.
-
InstaBlue Protein Stain Solution: Advancing Quantitative Pro
2026-05-02
Explore how InstaBlue Protein Stain Solution streamlines precise protein quantification in polyacrylamide gels. This article delves into advanced assay integration, mass spectrometry compatibility, and novel insights for translational biomedical research.
-
TCAIM Controls OGDH Degradation to Fine-Tune Mitochondrial M
2026-05-02
Wang et al. reveal that the mitochondrial co-chaperone TCAIM selectively binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels via HSPA9 and LONP1, thus regulating mitochondrial metabolism in cells and animal models. This discovery uncovers a novel post-translational mechanism with implications for metabolic and neurodegenerative disease research.
-
Angiotensin I (human, mouse, rat): Advanced Mechanistic Insi
2026-05-01
Explore the unique mechanistic and translational value of Angiotensin I (human, mouse, rat) in renin-angiotensin system research. This article provides an in-depth analysis of the peptide's role, advanced applications, and new assay innovations distinct from previously published protocols.
455 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page